Drug Shortage Report for TEVA-LACOSAMIDE

Last updated on 2019-10-10 History
Report ID 95387
Drug Identification Number 02472929
Brand name TEVA-LACOSAMIDE
Common or Proper name LACOSAMIDE TABS
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) LACOSAMIDE
Strength(s) 150MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 60
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-10-02
Estimated end date 2019-11-30
Actual end date 2019-10-09
Shortage status Resolved
Updated date 2019-10-10
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2019-10-10 French Compare
v3 2019-10-10 English Compare
v2 2019-10-03 French Compare
v1 2019-10-03 English Compare

Showing 1 to 4 of 4